Abstract:Antibodies with high targeting capability after being labelled by quantum dots (QDs) have been of great importance for in vitro diagnostic, cellular imaging and in vivo theranostic applications. However, such work concentrating on the conjugation of QDs and antibodies is still insufficient. It is encouraged to develop reliable bioconjugation strategies to improve detection sensitivity of QD-antibody bioconjugates. In this study, two bioconjugation approaches were used for antibody and QDs covalent coupling. Their detection sensitivity was parallelly determined and compared. It was experimentally found that succinimidyl valerate-PEG-maleimide (SMPEG) as the cross linker for oriented bioconjugation of antibodies to QDs with a flexible spacer arm can significantly improve the detection sensitivity of the resulting QD-antibody bioconjugates, compared with those prepared with traditional carbodiimide chemistry using EDC center dot HCl as the cross linker. Gel electrophoresis suggests antibodies can be successfully conjugated with QDs by both the EDC method and the SMPEG method, but immunofiltration assay shows QD-antibody bioconjugates obtained by the SMPEG strategy have lower detection limits and better linear scope patterns for in vitro molecular diagnosis. In vitro cancer cell imaging further shows that QD-antibody bioconjugates prepared by the SMPEG strategy have superior cell targeting capability without observable nonspecific binding, while the EDC-mediated QD-antibody bioconjugates have low signal to noise ratios with obvious nonspecific cellular binding. Moreover, the number of antibodies conjugated on the surface of QDs was determined by the chemiluminescent dot blot assay, showing 2.13 +/- 0.5 and 0.76 +/- 0.2 of antibodies per QD by EDC-mediated and SMPEG-mediated coupling, respectively. It further verifies that the SMPEG-mediated coupling strategy can significantly maintain the biological activity of the linked antibodies, even though it has low labelling efficiency. It could be therefore claimed that oriented bioconjugation via the SMPEG coupling strategy is favored by immunoassays, with improved detection sensitivity.

Simple Strategy for Single-Chain Fragment Antibody-Conjugated Probe Construction

Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging

Antibody-oriented strategy and mechanism for the preparation of fluorescent nanoprobes for fast and sensitive immunodetection.

Efficient Construction of PET/Fluorescence Probe Based on Sarcophagine Cage: an Opportunity to Integrate Diagnosis with Treatment

Antibody quantum dot conjugates developed via copper-free click chemistry for rapid analysis of biological samples using a microfluidic microsphere array system.

Single-band Upconversion Nanoprobes for Multiplexed Simultaneous in Situ Molecular Mapping of Cancer Biomarkers

Site-specific labeling of an anti-MUC1 antibody: probing the effects of conjugation and linker chemistry on the internalization process

Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells

Improving detection sensitivity by oriented bioconjugation of antibodies to quantum dots with a flexible spacer arm for immunoassay

Cyanine Conjugate‐Based Biomedical Imaging Probes

A Cation Exchange Strategy to Construct a Targeting Nanoprobe for Enhanced T1-weighted MR Imaging of Tumors

Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imaging

Protein-based tumor molecular imaging probes

Multi-shell structured fluorescent-magnetic nanoprobe for target cell imaging and on-chip sorting.

A Near-Infrared Fluorescent Probe With Assembly/Aggregation-Induced Retention Effect for Specific Diagnosis of Metastasis and Image-Guided Surgery in Breast Cancer

Nanocomoposite Probes Composed of Fluorescent Magnetic Nanoparticles and PSA ScFv Antibody for Targeted Imaging and Therapy of Prostate Cancer

Multivalent supramolecular fluorescent probes for accurate disease imaging

Rational design of nonlinear hybridization immunosensor chain reactions for simultaneous ultrasensitive detection of two tumor marker proteins.

Multifunctional nanoprobe for cancer cell targeting and simultaneous fluorescence/magnetic resonance imaging.

Engineering a Dual-Receptor Targeted Multivalent Probe for Enhanced Magnetic Resonance Imaging of Metastatic Cancer

A Dual Ligand Targeted Nanoprobe with High MRI Sensitivity for Diagnosis of Breast Cancer